[기업분석 레포트] 신한금융투자, Not Rating — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

IR Materials

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

IR Materials

Aug 28, 2020

[기업분석 레포트] 신한금융투자, Not Rating

- 반월공장 잔여 40% 공간에 대해서도 2차 추가 증설 발표 기대